Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Lemonaid Health vs Royal Medical Center

Lemonaid Health
Graded #488

Higher grade

vs+1.8000000000000043
Royal Medical Center
Graded #492

Lower grade

The verdict

Lemonaid Health takes it — 51.2/100 to 49.4/100, but only just.

Lemonaid Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth platform offering some of the lowest entry-tier GLP-1 program pricing on the market. Royal Medical Center is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRoyal Medical Center +2
20
22
Dose & formulationLemonaid Health +10
52
42
Clinical oversightLemonaid Health +12
74
62
Labs & monitoringRoyal Medical Center +33
53
86
FulfillmentLemonaid Health +33
81
48
Contract termsRoyal Medical Center +14
41
55
Lemonaid Health · left barRoyal Medical Center · right bar

The numbers

MetricLemonaid HealthRoyal Medical Center
WeighScore51.2/10049.4/100
GradeCC
Scorecard rank#488#492
Semaglutide$348/mo (starting dose, plus a separate fee, compounded)Not disclosed
TirzepatideNot disclosed$450/mo (2.5 mg dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Lemonaid Health

Graded #488 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
Royal Medical Center

Graded #492 · C

Strengths

  • Physician founder Dr. Dagoberto Rodriguez, MD — Emory residency, former Coral Springs Medical Center chairman, U Miami faculty
  • Tirzepatide pricing fully itemized by dose tier ($450 / $650 / $800 / $1,100) — more transparent than 'starting at' floors
  • All-inclusive pricing bundles medication, supplies, injections, lab monitoring, and physician follow-ups
  • Broad catalog (HRT, TRT, peptides, ED, hair, vitamins) reflects an established multi-program clinic
  • Florida physician with 30+ years of practice — a strong physician-led care signal

Where it loses points

  • Operating legal entity not disclosed — only the 'Royal Medical Center' brand surfaced
  • Pharmacy partner not named — buyers can't verify licensure or 503A/503B status
  • No LegitScript badge displayed
  • States served not enumerated — site says 'nationwide' with no state list
  • Headline 'starting at $116/mo' conflicts with the actual $450/mo tirzepatide floor

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard